Clinical Trials Logo
  1. Home
  2. Acute Coronary Syndrome
  3. NCT06075420

Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients — DAPTShort  

Acute Coronary Syndrome Clinical Trial

Official title:
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Short Duration of Dual Antiplatelet Therapy After Genoss DES Sirolimus-eluting Stent Implantation in Patients With Coronary Artery Disease

Clinical Trial Summary

The investigators aimed to evaluate the safety and effectiveness of short-term DAPT (3 months for SCAD, 6 months for ACS) after PCI with Genoss DES in patients with coronary artery disease.

Clinical Trial Description

This study is a sponsor-initiated clinical trial (SIT) that enrolls patients with coronary artery disease who have undergone percutaneous coronary intervention using the GENOSS DES stent as research subjects, collects data on the patients' clinical and surgical procedures, and reports on clinical events. The investigators will track the outbreak. This study is a prospective, multicenter registration observational study that will enroll patients with coronary artery disease who underwent percutaneous coronary intervention with GENOSS DES at a total of five institutions. This study is a registered observation study and does not separately calculate the number of subjects, but plans to recruit a total of 1,000 subjects during the study period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06075420
Study type Observational [Patient Registry]
Source Genoss Co., Ltd.
Contact YoungJin Youn
Phone 033-741-0910
Email younyj@yonsei.ac.kr
Status Recruiting
Phase
Start date July 8, 2021
Completion date December 31, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study